Skip to main content

PolyPid Ltd.

PYPD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001611842

No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding PolyPid Ltd. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of PYPD: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders1933+14
Shares3.12M3.28M+163.2K (+5.2%)
Value$13.7M$16.7M+$3.01M (+22.1%)

New holders (14)

Institutions that held PolyPid Ltd. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to PYPD in Q2 2026
InstitutionSharesValue% of portfolio
Marshall Wace, LLP115,014$584.3K0.00%
Quadrature Capital Ltd70,939$360.4K0.00%
Connective Capital Management, LLC67,600$343.4K0.24%
Susquehanna International Group, LLP40,027$203.3K0.00%
HRT Financial LP37,304$189.0K0.00%
Virtu Financial LLC18,851$96.0K0.00%
UBS Group AG18,484$93.9K0.00%
Axq Capital, LP17,097$86.9K0.01%
HighTower Advisors, LLC11,000$55.9K0.00%
Geode Capital Management, LLC10,197$51.8K0.00%
Simplex Trading, LLC463$2.35K0.00%
Group One Trading, L.P.330$1.68K0.00%
JPMorgan Chase & Co48$2390.00%
Rockefeller Capital Management L.P.33$1680.00%

Sold out (0)

Institutions that held PolyPid Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.

None.